MedTrace Logo

Clinical Study of Light Therapy to Control Myopia Progression in Children

NCT05761379 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2023-08-01

No results posted yet for this study

Summary

Low-lever red light therapy (LLLT) has been used to control myopia progression in China for a few years besides amblyopia therapy for a few decades. This study is to test the efficacy of PBM therapy to myopia children as well as to compare two types of PBM therapy to control myopia progression within one month.

Conditions

  • Myopia, Progressive

Interventions

DEVICE

Photobiomodualtion Therapy

low lever light therapy with laser semi-conductor at wavelength of 650nm

DEVICE

Single vision spectacles for correction myopia

Provide the distance best corrected vision acuity of refractive error of myopia for all the groups

Sponsors & Collaborators

  • Eye & ENT Hospital of Fudan University

    collaborator OTHER

  • Beijing Airdoc Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Xingtao Zhou, M.D. PhD. · Eye & ENT Hospital of Fudan University

  • Weicun Chen, MD, PhD · Eye & ENT Hospital of Fudan University

  • Meiyan Li, MD, PhD · Eye & ENT Hospital of Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-28
Primary Completion
2024-06-30
Completion
2024-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05761379 on ClinicalTrials.gov